The secretogranin II gene is a signal integrator of glutamate and dopamine inputs

J Neurochem. 2014 Jan;128(2):233-45. doi: 10.1111/jnc.12467. Epub 2013 Oct 24.

Abstract

Cooperative gene regulation by different neurotransmitters likely underlies the long-term forms of associative learning and memory, but this mechanism largely remains to be elucidated. Following cDNA microarray analysis for genes regulated by Ca(2+) or cAMP, we found that the secretogranin II gene (Scg2) was cooperatively activated by glutamate and dopamine in primary cultured mouse hippocampal neurons. The Ca(2+) chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid acetoxymethyl ester (BAPTA-AM) and the mitogen-activated protein kinase (MAPK) kinase (MEK) inhibitor PD98059 prevented Scg2 activation by glutamate or dopamine; thus, the Ca(2+) /MEK pathway is predicted to include a convergence point(s) of glutamatergic and dopaminergic signaling. Unexpectedly, the protein kinase A inhibitor KT5720 enhanced Scg2 activation by dopamine. The protein-synthesis inhibitor cycloheximide also enhanced Scg2 activation, and the proteasome inhibitor ZLLLH diminished the KT5720-mediated augmentation of Scg2 activation. These results are concordant with the notion that dopaminergic input leads to accumulation of a KT5720-sensitive transcriptional repressor, which is short-lived because of rapid degradation by proteasomes. This repression pathway may effectively limit the time window permissive to Scg2 activation by in-phase glutamate and dopamine inputs via the Ca(2+) /MEK pathway. We propose that the regulatory system of Scg2 expression is equipped with machinery that is refined for the signal integration of in-phase synaptic inputs. We proposed hypothetical mechanism for the regulation of the secretogranin II gene as a signal integrator of glutamate and dopamine inputs. Glutamate or dopamine activates the Ca(2+) /MEK/ERK pathway, which thus contributes to the signal integration. Concurrently, activation of the PKA inhibitor KT5720-sensitive pathway by dopamine leads to accumulation of the repressor protein X that is otherwise susceptible to proteasome degradation. This repression system may determine the time window permissive to the cooperative activation by in-phase glutamate and dopamine inputs.

Keywords: dopamine; glutamate; hippocampus; neurotransmission; secretogranin II; signal integrator.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bucladesine / pharmacology
  • Calcium / metabolism
  • Carbazoles / pharmacology
  • Cells, Cultured
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
  • Dopamine / metabolism*
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Glutamine / metabolism*
  • Hippocampus / cytology
  • Hippocampus / metabolism
  • Ionomycin / pharmacology
  • Mice
  • Neuroglia / drug effects
  • Neuroglia / metabolism
  • Neurons / drug effects
  • Neurons / metabolism
  • Neurotransmitter Agents / metabolism*
  • Oligonucleotide Array Sequence Analysis
  • Pyrroles / pharmacology
  • RNA, Messenger / metabolism
  • Secretogranin II / genetics
  • Secretogranin II / metabolism*
  • Signal Transduction

Substances

  • Carbazoles
  • Neurotransmitter Agents
  • Pyrroles
  • RNA, Messenger
  • Secretogranin II
  • secretogranin 2, mouse
  • Glutamine
  • Ionomycin
  • KT 5720
  • Bucladesine
  • Cyclic AMP-Dependent Protein Kinases
  • Extracellular Signal-Regulated MAP Kinases
  • Calcium
  • Dopamine